Aidea Pharma Deeply Involved! New National Guidelines for anti-HIV Drug Resistance Research Released — Joining Forces to Strengthen the Fight Against HIV

"Dual Advantages of Efficacy and Safety!" Real-World Data on Ainuovirine Regimen Highlights China's Achievements in Tokyo

Ainuomiti Tablets Sparks Heated Discussions at APACC Tokyo, Japan

China's Anti-HIV Innovative Drugs Step into Africa, Debut at INTEREST 2025

Youth Subgroup Study of Ainuomiti Tablets Selected for Oral Presentation at Asia-Pacific AIDS & Co-Infections Conference

The Light of National Innovation! 144-Week Data of Ainuomiti Tablets Released

Three-Year "iStudy Program" Successfully Concluded! Chinese Data Paves the Way for National Innovation in HIV Prevention and Treatment

First Overseas GMP Certificate! Aidea Pharma Obtains GMP Certificate from Zanzibar Food and Drug Agency

Breaking News丨Aidea Pharma and Nanda Pharma Obtain IND Approval for AD108 Injection, a New Drug for Stroke Treatment